The Food and Drug Administration (FDA) has authorized the marketing of ZYN nicotine pouch products, citing potential health benefits that outweigh the risks. The agency found that the pouches provide a harm reduction aid for smokers who wish to quit and reduce exposure to toxic substances.
However, concerns have been raised about youth use of the product, with data showing nearly double the use among teenagers from 2023 to 2024. A study published in the Journal of the American Medical Association found that nicotine pouches are gaining traction among high school students, with 5.4% of 10th- and 12th-grade students reporting use.
The FDA has warned that its marketing authorization does not mean the products are safe for all users, particularly youth. Researchers are monitoring the adoption of these highly addictive products, which deliver high doses of nicotine and raise concerns about addiction, dual use with other tobacco products, and long-term health consequences.
Experts have called for more monitoring and expanded regulations to address potential public health concerns, particularly among adolescents and young adults. The American Heart Association has issued a statement highlighting the negative cardiovascular effects of nicotine and the risk of mouth lesions from long-term use.
The tobacco industry’s shift towards diversifying its product line includes nicotine pouches, with firms like Philip Morris International committed to a “smoke-free future.” However, critics argue that the company’s marketing practices are not responsible enough.
Source: https://www.forbes.com/sites/joshuacohen/2025/07/04/rise-in-teenage-use-of-nicotine-pouches-in-us-has-some-experts-alarmed